查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1636351

按類型（第一期和第二期梅毒、潛伏和三期梅毒）、檢測地點（實驗室檢測、照護端 (POC) 檢測）和地區分類的梅毒檢測市場 2025-2033

Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球梅毒檢測IMARC Group規模達13億美元。性傳染病（STD）的日益普及、流產發生率的增加以及醫療保健領域對有效疾病診斷和測試解決方案的需求不斷增加是推動市場發展的一些關鍵因素。

梅毒是指一種性傳染感染（STI），通常由性接觸引起，並透過皮膚或黏膜接觸在個體之間傳播。它開始時是生殖器和口腔直腸上的無痛潰瘍。如果不及時治療，可能會引發第三期梅毒的併發症，這種疾病可能會損害大腦、神經、血管和關節。目前，快速血漿反應素（RPR）和性病研究實驗室（VDRL）是從業人員正在使用的標準測試實踐。這些方法提供早期檢測，以便更好地治療，並減輕性傳染病 (STD) 的傳播和發展。因此，實驗室和照護端 (PoC) 中心經常使用梅毒檢測來診斷梅毒類型並確定其適當的治療方法。

梅毒檢測市場趨勢：

對性病治療的認知不斷提高是推動市場成長的關鍵因素之一。為此，各國政府以及不同的非政府組織（NGO）正積極進行宣傳活動，提高公眾對預防包括梅毒在內的性傳染病和現有治療方案的認知。這反過來又促進了梅毒快速檢測試紙等梅毒檢測試劑盒的採用，從而有利地支持了市場成長。這些試劑盒提供家庭測試和有效的診斷結果，以便及時做出決策，這也有助於市場的成長。此外，這些測試套件使用方便，並且可以在網上零售店和店內藥房以實惠的價格輕鬆獲得，這也促進了市場的成長。除此之外，醫療保健領域的顯著改善以及最近推出有效治療替代方案的研發（R＆D）活動正在對市場成長產生積極影響。此外，針對性傳播感染檢測的優惠醫療報銷政策的存在也促進了市場的成長。其他因素，例如包括梅毒在內的性病患病率不斷上升、無保護性交發生率上升、有效篩檢計畫的廣泛實施以及對疾病早期診斷的重視，正在為市場創造積極的前景。

本報告回答的關鍵問題：

  • 迄今為止，全球梅毒檢測市場的表現如何？
  • 全球梅毒檢測市場的促進因素、限制因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的梅毒檢測市場？
  • 依類型分類市場是怎麼樣的？
  • 根據測試地點的市場分類是怎樣的？
  • 全球梅毒檢測市場的競爭格局如何？
  • 全球梅毒檢測市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球梅毒檢測市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 一期和二期梅毒
    • 市場趨勢
    • 市場預測
  • 潛伏梅毒和第三期梅毒
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按測試地點

  • 實驗室測試
    • 市場趨勢
    • 市場預測
  • 即時護理 (POC) 測試
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • DRG International Inc. (BioCheck Inc.)
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers AG (Siemens AG)
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A6876

The global syphilis testing market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences of miscarriages, and the rising need for effective disease diagnosing and testing solutions in the healthcare sector represent some of the key factors driving the market.

Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints. At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.

Syphilis Testing Market Trends:

The increasing awareness regarding STD treatment represents one of the key factors driving the market growth. In line with this, governments of various nations, along with different non-governmental organizations (NGOs) are actively undertaking campaigns to sensitize the common mass regarding the prevention of STDs, including syphilis, and the available treatment options. This, in turn, is facilitating the adoption of syphilis testing kits, such as syphilis rapid test strips, which is favorably supporting the market growth. These kits offer at-home testing with effective diagnostic results, and thus timely decision-making, which is also contributing to the market growth. Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth. Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.

Key Market Segmentation:

Type Insights:

  • Primary and Secondary Syphilis
  • Latent and Tertiary Syphilis
  • The report has also provided a detailed breakup and analysis of the syphilis testing market based on the type. This includes primary and secondary, and latent and tertiary syphilis. According to the report, primary and secondary syphilis represented the largest segment.

Location of Testing Insights:

  • Laboratory Testing
  • Point-of-Care (POC) Testing

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for syphilis testing. Some of the factors driving the North America syphilis testing market included the increasing prevalence of STDs, significant technological advancements, and extensive research and development (R&D) activities.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global syphilis testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, DRG International Inc. (BioCheck Inc.), F. Hoffmann-La Roche AG, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global syphilis testing market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global syphilis testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive syphilis testing markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the location of testing?
  • What is the competitive structure of the global syphilis testing market?
  • Who are the key players/companies in the global syphilis testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Syphilis Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Primary and Secondary Syphilis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Latent and Tertiary Syphilis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Location of Testing

  • 7.1 Laboratory Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point-of-Care (POC) Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Danaher Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 DRG International Inc. (BioCheck Inc.)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 F. Hoffmann-La Roche AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Siemens Healthineers AG (Siemens AG)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Thermo Fisher Scientific Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Syphilis Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Syphilis Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Syphilis Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Syphilis Testing Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Syphilis Testing Market: Breakup by Location of Testing (in %), 2024
  • Figure 6: Global: Syphilis Testing Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Syphilis Testing (Primary and Secondary Syphilis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Syphilis Testing (Primary and Secondary Syphilis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Syphilis Testing (Laboratory Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Syphilis Testing (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: North America: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: North America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: United States: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: United States: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Canada: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Canada: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Asia-Pacific: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Asia-Pacific: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: China: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: China: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Japan: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Japan: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: India: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: India: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: South Korea: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: South Korea: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Australia: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Australia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Indonesia: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Indonesia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Others: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Europe: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Europe: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Germany: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Germany: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: France: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: France: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United Kingdom: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United Kingdom: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Italy: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Italy: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Spain: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Spain: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Russia: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Russia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Latin America: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Latin America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Brazil: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Brazil: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Mexico: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Mexico: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Middle East and Africa: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Middle East and Africa: Syphilis Testing Market: Breakup by Country (in %), 2024
  • Figure 63: Middle East and Africa: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Global: Syphilis Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 65: Global: Syphilis Testing Industry: Value Chain Analysis
  • Figure 66: Global: Syphilis Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Syphilis Testing Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Syphilis Testing Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Syphilis Testing Market Forecast: Breakup by Location of Testing (in Million USD), 2025-2033
  • Table 4: Global: Syphilis Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Syphilis Testing Market: Competitive Structure
  • Table 6: Global: Syphilis Testing Market: Key Players